BIOTECH/PHARMA COMPANY

Corporations or other life sciences entities that use biotechnology or related technologies for research and development of therapeutic drugs, diagnostics, genomics, or digital therapeutics.

EMERGING INNOVATORS TRACK COMPANY (NEW) 

Corporations qualifying for the Emerging Innovators Track discounted rates include only the following: Emerging Innovators Track corporations are biotech and related companies that have cumulatively raised at least $9M, but less than $25M total through October 2019. For this event, Emerging Innovator Track companies must use biotechnology or related technologies to conduct or support research and development of drug products, diagnostics, or digital therapeutics intended for regulatory approval or already under regulatory review.  

DISCOVERY TRACK COMPANY

Corporations qualifying for the Discovery Track discounted rates include only the following: Discovery Track corporations are "pre-emerging" biotech and related companies, qualifying as seed and A-round companies that have raised since founding less than $9M total through October 2019. For this event, Discovery Track companies must use biotechnology or related technologies to conduct or support research and development of drug products, diagnostics, or digital therapeutics intended for regulatory approval or already under regulatory review.

INVESTORS

BIO events attract the most sophisticated investors in the life science community and provide a robust forum for this community to engage in the advancement of promising technologies that improve and save lives. BIO is pleased to provide complimentary registration to qualified investors under BIO’s revised investor policy.

Qualified investors are defined as institutional, private equity, angel and venture investors with funds on-hand, whose primary activity is direct investment in research and development companies (e.g., hedge fund, mutual fund, or venture fund). Equity research analysts from investment banking institutions and buy-side analysts also qualify as investors.

The fund name, portfolio type, and other helpful information is needed for BIO to process your registration appropriately. Receipt of complimentary registration for a prior year's event does not automatically qualify a registrant for complimentary registration in 2019. In cases where no information is attainable via investor relations databases and/or internet searches may be required to provide additional information. 

Organizations who apply for investor registration, that have a service providing component to their business model, such as investor relations, contract services, organizations or who host competitive events will be ineligible for complimentary investor registration. Should BIO discover undisclosed information about an organization's business model AFTER an application has been approved, it may be rescinded at BIO’s discretion.  Please contact register@bio.org for more information.

ACADEMIC/GOVERNMENT/NON-PROFIT

Attendees affiliated with accredited government or academic institution. Attendees must show proof through business card or ID on-site. To be eligible for the non-profit registration category, the attendee must show proof of working for an organization that has already received 501(c)(3) status from the Internal Revenue Service.

MEDIA REGISTRATION

Media registration is open to editors and reporters working full time for print, broadcast or web publications with valid press credentials. Information on advance media registration for the BIO Investor Forum will be available in June 2019.

SERVICE PROVIDERS/SUPPLIERS

Corporations or other for-profit entities that provide services or products to biotechnology and other companies. Service providers include investment and merchant bankers and representatives of law, accounting, consulting, contract manufacturers, active pharmaceutical ingredient manufacturers, contract research organizations, real estate development, and economic development organizations. Service providers cannot register with presenting companies unless approved by BIO and do not receive access to BIO One-on-One Partnering™.

For service providers to access the BIO One-on-One Partnering system, the organization must sponsor at a specific level. Contact sponsor@bio.org to receive more information from our Sales and Sponsorship team.

For the purposes of registration for any BIO event, conference or meeting, the classification of a registrant as a research and development company, academic & government or a qualifying investor is subject to review by BIO. In its sole discretion, BIO reserves the right to make the determination of the proper classification of a registrant. Depending on this classification, an additional registration fee maybe required. BIO reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations..